Green Cross Lab Cell Corporation (144510) — Financial Flexibility Index
Green Cross Lab Cell Corporation (144510) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of ₩7.29 Billion (operating CF ₩6.67 Billion minus capex ₩624.50 Million) represents 0% of total liabilities (₩134.23 Billion). Check 144510 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Green Cross Lab Cell Corporation Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Green Cross Lab Cell Corporation across 10 annual periods. See Green Cross Lab Cell Corporation (144510) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year free cash flow to debt coverage for Green Cross Lab Cell Corporation. For the full company profile including market capitalisation, see market value of Green Cross Lab Cell Corporation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | ₩17.38 Billion | ₩11.34 Billion | ₩120.56 Billion | ▼ -19.2% |
| 2023 | 0.18x | ₩22.07 Billion | ₩3.67 Billion | ₩123.69 Billion | ▼ -66.4% |
| 2022 | 0.53x | ₩73.33 Billion | ₩66.42 Billion | ₩138.07 Billion | ▲ +105.5% |
| 2021 | 0.26x | ₩34.78 Billion | ₩23.91 Billion | ₩134.57 Billion | ▼ -45.6% |
| 2020 | 0.48x | ₩13.88 Billion | ₩9.09 Billion | ₩29.19 Billion | ▲ +105.2% |
| 2019 | 0.23x | ₩5.57 Billion | ₩223.04 Million | ₩24.02 Billion | ▼ -58.0% |
| 2018 | 0.55x | ₩5.27 Billion | ₩490.92 Million | ₩9.55 Billion | ▼ -16.3% |
| 2017 | 0.66x | ₩4.64 Billion | ₩2.86 Billion | ₩7.03 Billion | ▲ +657.0% |
| 2016 | 0.09x | ₩558.94 Million | ₩-296.65 Million | ₩6.42 Billion | ▼ -70.4% |
| 2015 | 0.29x | ₩2.32 Billion | ₩1.49 Billion | ₩7.90 Billion | — |